mhurhangee/patent-ind-claim-en huggingface dataset:
A lens for non-prescription eyewear, comprising: a first surface having a first surface shape; and a second surface opposite the first surface, the second surface having a second surface shape, wherein the first and second surfaces are aspherized to reduce both a component of an optical power and a measure of distortion of the lens, wherein the first surface includes a point of maximum curvature and the curvature of the first surface measured along a line from the point of maximum curvature and another point on the first surface decreases by at least 1.5 diopters at a distance 15 mm in every direction from the point of maximum curvature, the first and second surface shapes define at least a portion of the lens having a dimension of at least 30 mm such that the portion includes the point of maximum curvature of the first surface, wherein a component of an optical power of the lens varies by less than 0.03 diopters over the portion, and wherein a measure of distortion of the lens varies by 0.1% or less over the portion. a first surface having a first surface shape; and a second surface opposite the first surface, the second surface having a second surface shape, wherein the first and second surfaces are aspherized to reduce both a component of an optical power and a measure of distortion of the lens, wherein the first surface includes a point of maximum curvature and the curvature of the first surface measured along a line from the point of maximum curvature and another point on the first surface decreases by at least 1.5 diopters at a distance 15 mm in every direction from the point of maximum curvature, the first and second surface shapes define at least a portion of the lens having a dimension of at least 30 mm such that the portion includes the point of maximum curvature of the first surface, wherein a component of an optical power of the lens varies by less than 0.03 diopters over the portion, and wherein a measure of distortion of the lens varies by 0.1% or less over the portion.
A process for removing C 5 -C 8 -hydrocarbons and acid gases from a fluid stream, wherein a) the fluid stream is brought into contact with an absorption medium comprising at least one amine in an absorption zone to obtain a deacidified fluid stream and an acid-gases-laden absorption medium, b) the laden absorption medium is heated in a first heat exchanger and decompressed into a decompression zone to a pressure of from 5 to 10 bar to obtain a C 5 -C 8 -hydrocarbons-comprising gas phase and a hydrocarbon-depleted laden absorption medium, c) the hydrocarbon-depleted laden absorption medium is passed into a stripper in which at a pressure of 1 to 2.5 bar the acid gases are at least partially liberated by supplying heat to obtain a regenerated absorption medium and an acid-gas-comprising stream, the hydrocarbon-depleted laden absorption medium optionally being heated in a second heat exchanger before being introduced into the stripper, and d) the regenerated absorption medium is recycled into the absorption zone, wherein, if the second heat exchanger is present, the heating medium used in the second heat exchanger is the regenerated absorption medium and the heating medium used in the first heat exchanger is the regenerated absorption medium after it has passed through the second heat exchanger, or, if the second heat exchanger is not present, the heating medium used in the first heat exchanger is the regenerated absorption medium, and the amount of heat transferred in the first heat exchanger is such that the C 5 -C 8 -hydrocarbons-comprising gas phase comprises 50% to 97% by volume of acid gases. a) the fluid stream is brought into contact with an absorption medium comprising at least one amine in an absorption zone to obtain a deacidified fluid stream and an acid-gases-laden absorption medium, b) the laden absorption medium is heated in a first heat exchanger and decompressed into a decompression zone to a pressure of from 5 to 10 bar to obtain a C 5 -C 8 -hydrocarbons-comprising gas phase and a hydrocarbon-depleted laden absorption medium, c) the hydrocarbon-depleted laden absorption medium is passed into a stripper in which at a pressure of 1 to 2.5 bar the acid gases are at least partially liberated by supplying heat to obtain a regenerated absorption medium and an acid-gas-comprising stream, the hydrocarbon-depleted laden absorption medium optionally being heated in a second heat exchanger before being introduced into the stripper, and d) the regenerated absorption medium is recycled into the absorption zone,
A system for monitoring nerve activity in a subject comprising: a plurality of electrodes configured to engage a subject's skin; a signal detector configured to sample electrical signals detected proximate to the subject's skin by the plurality of electrodes ; and a signal processor configured to: receive signal data corresponding to the electrical signals sampled by the signal detector; apply a filter to the signal data to generate filtered signal data, the filter configured to attenuate in the signal data at least frequencies corresponding to heart muscle activity during a heartbeat; identify a skin nerve activity using the filtered signal data; estimate a sympathetic nerve activity using predetermined correlations or relationships, stored in a memory , between the skin nerve activity and the sympathetic nerve activity; generate a report indicative of the estimated sympathetic nerve activity. a plurality of electrodes configured to engage a subject's skin; a signal detector configured to sample electrical signals detected proximate to the subject's skin by the plurality of electrodes ; and a signal processor configured to: receive signal data corresponding to the electrical signals sampled by the signal detector; apply a filter to the signal data to generate filtered signal data, the filter configured to attenuate in the signal data at least frequencies corresponding to heart muscle activity during a heartbeat; identify a skin nerve activity using the filtered signal data; estimate a sympathetic nerve activity using predetermined correlations or relationships, stored in a memory , between the skin nerve activity and the sympathetic nerve activity; generate a report indicative of the estimated sympathetic nerve activity. receive signal data corresponding to the electrical signals sampled by the signal detector; apply a filter to the signal data to generate filtered signal data, the filter configured to attenuate in the signal data at least frequencies corresponding to heart muscle activity during a heartbeat; identify a skin nerve activity using the filtered signal data; estimate a sympathetic nerve activity using predetermined correlations or relationships, stored in a memory , between the skin nerve activity and the sympathetic nerve activity; generate a report indicative of the estimated sympathetic nerve activity.
A stapling assembly for use with a surgical stapler, comprising: a cartridge having a first longitudinal row of first staples disposed therein, the first staples being configured to be deployed into tissue; and a non-fibrous adjunct formed of at least one fused bioabsorbable polymer and configured to be releasably retained on the cartridge such that the adjunct can be attached to tissue by the staples in the cartridge , the adjunct comprises a lattice structure having a first longitudinal row of first repeating unit cells (2716a-e), each unit cell having a non-uniform thickness characterized in that the non-uniform thickness is such that first and second staples legs of the first staples advance through different portions of the adjunct as the first staples are deployed into tissue, wherein the different portions of the adjunct have different relative thicknesses. a cartridge having a first longitudinal row of first staples disposed therein, the first staples being configured to be deployed into tissue; and a non-fibrous adjunct formed of at least one fused bioabsorbable polymer and configured to be releasably retained on the cartridge such that the adjunct can be attached to tissue by the staples in the cartridge , the adjunct comprises a lattice structure having a first longitudinal row of first repeating unit cells (2716a-e), each unit cell having a non-uniform thickness characterized in that the non-uniform thickness is such that first and second staples legs of the first staples advance through different portions of the adjunct as the first staples are deployed into tissue, wherein the different portions of the adjunct have different relative thicknesses.
An apparatus for reducing motion artifact in an ECG signal of a patient, the apparatus comprising: a calculating unit configured to calculate a mean value beat from the ECG signal; a first obtaining unit configured to obtain a residual signal based on the ECG signal and the mean value beat calculated from the ECG signal; a filtering unit configured to perform filtering of the residual signal with one or more cut off frequencies; and a second obtaining unit configured to obtain a modified ECG signal based on the filtered residual signal and the mean value beat; characterized in that the apparatus further comprises a determining unit configured to determine the one or more cut off frequencies of the filtering based on an acceleration signal representative of motion status of the patient; wherein the one or more cut off frequencies of the filtering comprise a signal frequency of the acceleration signal; and wherein the filtering unit comprises a band-stop filter with a cut off frequency determined by the determining unit to block the signal frequency of the acceleration signal. a calculating unit configured to calculate a mean value beat from the ECG signal; a first obtaining unit configured to obtain a residual signal based on the ECG signal and the mean value beat calculated from the ECG signal; a filtering unit configured to perform filtering of the residual signal with one or more cut off frequencies; and a second obtaining unit configured to obtain a modified ECG signal based on the filtered residual signal and the mean value beat; characterized in that the apparatus further comprises a determining unit configured to determine the one or more cut off frequencies of the filtering based on an acceleration signal representative of motion status of the patient; wherein the one or more cut off frequencies of the filtering comprise a signal frequency of the acceleration signal; and wherein the filtering unit comprises a band-stop filter with a cut off frequency determined by the determining unit to block the signal frequency of the acceleration signal.
A device for conveying smoking articles or parts of smoking articles, comprising: - a first rotor , rotatable about a first rotation axis (I1); - a second rotor , rotatable about a second rotation axis (I2) parallel to the first rotation axis (I1) and moved away with respect to the latter along a reference axis (R); and - a plurality of conveying members for receiving smoking articles or parts of smoking articles, which are mounted on the second rotor , according to a arrangement in series around the second rotation axis (I2), and each one is rotatable about a respective rotation axis (Ii) parallel to the second rotation axis (I2) of the second rotor ; - a plurality of members for rotationally connecting the first rotor to the second rotor , which are arranged in series around the first and the second rotation axis (I1, I2), and each have a first end that is coupled in a rotatable manner to the first rotor , and a second end that is coupled in a rotatable manner to the second rotor , and is fixed to a respective conveying member of the plurality of conveying members; said device being characterized in that : - each connecting member comprises a weakened portion such that it causes a privileged deformation of the connecting member inducing a movement of the first end with respect to the second end , along a direction parallel to the reference axis (R). - a first rotor , rotatable about a first rotation axis (I1); - a second rotor , rotatable about a second rotation axis (I2) parallel to the first rotation axis (I1) and moved away with respect to the latter along a reference axis (R); and - a plurality of conveying members for receiving smoking articles or parts of smoking articles, which are mounted on the second rotor , according to a arrangement in series around the second rotation axis (I2), and each one is rotatable about a respective rotation axis (Ii) parallel to the second rotation axis (I2) of the second rotor ; - a plurality of members for rotationally connecting the first rotor to the second rotor , which are arranged in series around the first and the second rotation axis (I1, I2), and each have a first end that is coupled in a rotatable manner to the first rotor , and a second end that is coupled in a rotatable manner to the second rotor , and is fixed to a respective conveying member of the plurality of conveying members; - each connecting member comprises a weakened portion such that it causes a privileged deformation of the connecting member inducing a movement of the first end with respect to the second end , along a direction parallel to the reference axis (R).
Heat exchange system for a building, comprising a housing which contains a supply flow passage and a discharge flow passage , a heat exchanger by means of which the supply flow passage and the discharge flow passage are in a heat-exchanging relationship to each other, a main air supply connection at one end of the supply flow passage, at the other end of which supply flow passage at least two secondary air supply connections are located, wherein the one end of the supply flow passage and the other end of the supply flow passage are located respectively upstream and downstream from the heat exchanger , a main air discharge connection at one end of the discharge flow passage, at the other end of which discharge flow passage exactly one secondary air discharge connection is located, a first booster adapted to supply air from outside the building through the main air supply connection via the supply flow passage and the secondary air supply connections into the building, and a second booster adapted to discharge air from the building via the secondary air discharge connection, the discharge flow passage and the main air discharge connection, wherein the housing is provided with at least one flow regulator which is located between the heat exchanger and a secondary air supply connection , characterized in that the at least one flow regulator forms part of a cassette and the housing is provided with a cassette chamber in which the cassette is received.
A composition for reducing microbial activity in an environment susceptible to microbial activity, comprising: metallic nanoparticles; and an oxygenation agent, wherein the metallic nanoparticles comprise gold nanoparticles, wherein the oxygenation agent is hydrogen peroxide, and wherein the composition further comprises a mineralization agent, wherein the mineralization agent is selected from the group consisting of calcium phosphate, dicalcium phosphate, tricalcium phosphate and calcium bicarbonate. metallic nanoparticles; and an oxygenation agent, wherein the metallic nanoparticles comprise gold nanoparticles, wherein the oxygenation agent is hydrogen peroxide, and wherein the composition further comprises a mineralization agent, wherein the mineralization agent is selected from the group consisting of calcium phosphate, dicalcium phosphate, tricalcium phosphate and calcium bicarbonate.
A method of quantifying mRNA capping efficiency, the method comprising: (i) an in vitro transcription reaction comprising: (a) in vitro transcribing of mRNA; and (b) incorporating a cap analog, (ii) a quantification step comprising: (a) providing a cap specific binding substance under conditions that permit the formation of a complex between the cap specific binding substance and the capped mRNA; and (b) quantitatively determining the amount of the complex as compared to a control, thereby quantifying mRNA capping efficiency, wherein in vitro transcription comprises at least a phage RNA polymerase, a DNA template containing a phage polymerase promoter, nucleotides, and a buffer containing a magnesium salt. (i) an in vitro transcription reaction comprising: (a) in vitro transcribing of mRNA; and (b) incorporating a cap analog, (a) in vitro transcribing of mRNA; and (b) incorporating a cap analog, (ii) a quantification step comprising: (a) providing a cap specific binding substance under conditions that permit the formation of a complex between the cap specific binding substance and the capped mRNA; and (b) quantitatively determining the amount of the complex as compared to a control, thereby quantifying mRNA capping efficiency, (a) providing a cap specific binding substance under conditions that permit the formation of a complex between the cap specific binding substance and the capped mRNA; and (b) quantitatively determining the amount of the complex as compared to a control, thereby quantifying mRNA capping efficiency,
A method for moving a refrigerated counter with a product space as well as with an operator side and a customer side , wherein the product space can be accessed in an operating state from the operator side to an extent sufficient for operation, and on the customer side has a product protector that protects against contamination or undesired access by customers and comprises a product shelter as well as a money tray , and in a self-service state can be accessed from the customer side to an extent sufficient for self-service, from the operating state in the self-service state , wherein the money tray is moved from an operating position into a self-service position that releases the product shelter from the operator side and from the customer side and/or from a self-service position that releases the product shelter from the operator side and from the customer side into an operating position, characterized in that the self-service position is located below the height of a countertop provided on the operator side .
A method for operating a drive system of a submarine with at least one electrical traction network for supplying at least one consumer with electrical energy, wherein at least two parallel battery banks , each of which is linked to the traction network by a DC-DC converter , are assigned to each traction network , wherein the respective states of charge (SOC) of the at least two battery banks of a traction network are synchronized with each other by the SOC of each battery bank being measured in each case by a battery management system (BMS) , and a bank voltage of each battery bank being set by the respective DC-DC converter on the basis of a characteristic curve for the respective battery bank depending on the measured SOC, wherein the battery bank , for which a higher SOC was measured than in the case of a parallel battery bank of the same traction network , feeds a higher current into the traction network , than the battery bank for which a lower SOC was measured characterized in that on a current limitation of the battery bank with the higher SOC being reached or on reduction of the SOC, the traction network voltage is reduced.
A nanoemulsion comprising a population of particles, wherein the majority of particles have diameters between 10 and 300 nanometers and wherein the nanoemulsion comprises an oil, a surfactant and a botulinum toxin, wherein the oil and surfactant are present in a ratio of ranging from 0.5-2.0, wherein the nanoemulsion is for use in reducing at least one symptom of a disorder associated with the dermal level of the skin, wherein the nanoemulsion can penetrate the top layer of the skin without the use of chemical or mechanical skin permeation enhancers or abrasives; wherein the disorder associated with the dermal level of the skin is rosacea or an excess sebum-producing disorder; and optionally wherein the botulinum toxin is a) encapsulated within the particles, b) adsorbed on the surface of the particles, c) associated with the particle interface, d) selected from the group comprising type A, type B, type C1, type C2, type D, type E, type F and type G, e) a botulinum toxin complex, f) incorporated within an albumin matrix, g) not incorporated within an albumin matrix, h) a purified botulinum toxin protein or fragment thereof, i) isolated, or substantially isolated, from other proteins, j) isolated, or substantially isolated, from non-toxin proteins, k) chemically synthesized, l) produced recombinantly, m) a fragment of a wild-type toxin, or n) contains at least one mutation relative to the wild-type toxin. a) encapsulated within the particles, b) adsorbed on the surface of the particles, c) associated with the particle interface, d) selected from the group comprising type A, type B, type C1, type C2, type D, type E, type F and type G, e) a botulinum toxin complex, f) incorporated within an albumin matrix, g) not incorporated within an albumin matrix, h) a purified botulinum toxin protein or fragment thereof, i) isolated, or substantially isolated, from other proteins, j) isolated, or substantially isolated, from non-toxin proteins, k) chemically synthesized, l) produced recombinantly, m) a fragment of a wild-type toxin, or n) contains at least one mutation relative to the wild-type toxin.
An agrochemical formulation comprising; i) an adjuvant; and ii) at least one agrochemical active; wherein said adjuvant has general structure (I): Sorb.(AO 1 H) n1 (AO 2 H) n2 (AO 3 H) n3 (AO 4 R 1 ) n4 (I) wherein; Sorb represents a residue of 1,4-anhydrosorbitol, 1,5 anhydrosorbitol, or 3,6-anhydrosorbitol; AO 1 , AO 2 , AO 3 , and AO 4 each independently represents an oxyalkylene group formed from oxyethylene units, oxypropylene units, or a mixture thereof, wherein each oxyalkylene group AO 1 , AO 2 , AO 3 , and AO 4 comprises a mixture of oxyethylene and oxypropylene units; n1, n2, and n3 each independently represent an integer having a value of 0 or 1; n4 represents a value of 1; R 1 represents an alkanoyl group -C(O)R 2 wherein R 2 represents a C 4 to C 28 hydrocarbyl; wherein the number of moles of oxyethylene and oxypropylene present in each oxyalkylene group is independently an integer in the range from 1 to 8; wherein each oxyalkylene group is a block copolymer; and wherein the total number of moles of oxyethylene units present in each adjuvant molecule has an integer value in the range of from 4 to 18 and the total number of moles of oxypropylene units in each adjuvant molecule is in the range from 2 to 17. i) an adjuvant; and ii) at least one agrochemical active; Sorb represents a residue of 1,4-anhydrosorbitol, 1,5 anhydrosorbitol, or 3,6-anhydrosorbitol; AO 1 , AO 2 , AO 3 , and AO 4 each independently represents an oxyalkylene group formed from oxyethylene units, oxypropylene units, or a mixture thereof, wherein each oxyalkylene group AO 1 , AO 2 , AO 3 , and AO 4 comprises a mixture of oxyethylene and oxypropylene units; n1, n2, and n3 each independently represent an integer having a value of 0 or 1; n4 represents a value of 1; R 1 represents an alkanoyl group -C(O)R 2 wherein R 2 represents a C 4 to C 28 hydrocarbyl; wherein the number of moles of oxyethylene and oxypropylene present in each oxyalkylene group is independently an integer in the range from 1 to 8; wherein each oxyalkylene group is a block copolymer; and wherein the total number of moles of oxyethylene units present in each adjuvant molecule has an integer value in the range of from 4 to 18 and the total number of moles of oxypropylene units in each adjuvant molecule is in the range from 2 to 17.